Citation Impact
Citing Papers
Neutralizing antibody response during acute and chronic hepatitis C virus infection
2004 StandoutNobel
Vaccine-delivered HIV envelope inhibits CD4+ T-cell activation, a mechanism for poor HIV vaccine responses
2006 StandoutNobel
Specific Immune Induction Following DNA-Based Immunization Through In Vivo Transfection and Activation of Macrophages/Antigen-Presenting Cells
1998
Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model.
1998
Prevalence of Local Immune Response against Oral Infection in a Drosophila/Pseudomonas Infection Model
2006
Assaying the Drosophila Negative Feedback Loop with RNA Interference in S2 Cells
2005 StandoutNobel
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Enhanced efficacy of DNA vaccination against Her‐2/neu tumor antigen by genetic adjuvants
2004
A Toll-like receptor recognizes bacterial DNA
2000 StandoutNature
DNA-Based Vaccine against La Crosse Virus: Protective Immune Response Mediated by Neutralizing Antibodies and CD4+ T Cells
1999
Molecular mechanisms of HIV-1 associated neurodegeneration
2005
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes
2001 StandoutNobel
Co-delivery of plasmid-encoded cytokines modulates the immune response to a DNA vaccine delivered by in vivo electroporation
2006
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV
2000
Characterization of two novel regulatory genes affecting Salmonella invasion gene expression
2000
Mucosal immunity and vaccines
2005 Standout
Bacteria as DNA vaccine carriers for genetic immunization
2004
Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine
2001 StandoutScience
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
1999 StandoutNobel
Prospects for a vaccine against the hepatitis C virus
2005 StandoutNatureNobel
Biofilms: an emergent form of bacterial life
2016 Standout
Antibodies to Core Lipopolysaccharide Determinants: Absence of Cross-reactivity with Heterologous Lipopolysaccharides
1991
University of California/Davis Interdepartmental Conference on Gram-Negative Septicemia
1991 StandoutNobel
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Suramin inhibits hepatic tissue damage in hepatocellular carcinoma through deactivation of heparanase enzyme
2014
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
DNA vaccines for HIV: challenges and opportunities
2006
Single-domain antibodies as building blocks for novel therapeutics
2008
DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface
1999
Transport of Nanoparticles Across the Rat Nasal Mucosa
2001
THE MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
1999
Genetic adjuvants for DNA vaccines
2001
Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1env/revDNA Vaccine Induces Antigen‐Specific Proliferation and Lymphocyte Production of β‐Chemokines
2000
Improving the efficiency of RNA interference in mammals
2004
The Drosophila systemic immune response: sensing and signalling during bacterial and fungal infections
2007 StandoutNobel
New prospects for the development of a vaccine against human immunodeficiency virus type 1. An overview
1999
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
Revealing the world of RNA interference
2004 StandoutNatureNobel
Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice
1997
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science
2001 Standout
Toxicology of antisense therapeutics
2004
Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
1999
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Immune Recognition of Foreign DNA
1999
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
1993 StandoutNature
Characterization of the Peptide Binding Motif of a Rhesus MHC Class I Molecule (Mamu-A*01) That Binds an Immunodominant CTL Epitope from Simian Immunodeficiency Virus
1998
Conserved CTL Epitopes Shared Between HIV-Infected Human Long-Term Survivors and Chimpanzees
1999
Genetic Immunization Generates Cellular and Humoral Immune Responses Against the Nonstructural Proteins of the Hepatitis C Virus in a Murine Model
1998
Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity
1997
Induction of Broad CD4+and CD8+T-Cell Responses and Cross- Neutralizing Antibodies against Hepatitis C Virus by Vaccination with Th1-Adjuvanted Polypeptides Followed by Defective Alphaviral Particles Expressing Envelope Glycoproteins gpE1 and gpE2 and Nonstructural Proteins 3, 4, and 5
2008 StandoutNobel
Evaluation of Hepatitis C Virus Glycoprotein E2 for Vaccine Design: an Endoplasmic Reticulum-Retained Recombinant Protein Is Superior to Secreted Recombinant Protein and DNA-Based Vaccine Candidates
2000 StandoutNobel
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
2017
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Progress in the Development of an HIV-1 Vaccine
1998 Science
Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen
2001
Enhancing B- and T-Cell Immune Response to a Hepatitis C Virus E2 DNA Vaccine by Intramuscular Electrical Gene Transfer
2000
Cell-to-Cell Contact Results in a Selective Translocation of Maternal Human Immunodeficiency Virus Type 1 Quasispecies across a Trophoblastic Barrier by both Transcytosis and Infection
2001 StandoutNobel
Synthesis of group A streptococcal virulence factors is controlled by a regulatory RNA molecule
2004 StandoutNobel
Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen
2000
Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage ofMycobacterium tuberculosisHeat Shock Protein 70 Gene to an Antigen Gene
2001 StandoutNobel
Progress in the Delivery of Therapeutic Oligonucleotides: Organ/Cellular Distribution and Targeted Delivery of OligonucleotidesIn Vivo
2003
Expression of Noncovalent Hepatitis C Virus Envelope E1-E2 Complexes Is Not Required for the Induction of Antibodies with Neutralizing Properties following DNA Immunization
1999
Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus
1998
Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia
1999
Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques
2002
Simian Immunodeficiency Virus (SIV)gagDNA-Vaccinated Rhesus Monkeys Develop Secondary Cytotoxic T-Lymphocyte Responses and Control Viral Replication after Pathogenic SIV Infection
2000
Comparison of Immunity Generated by Nucleic Acid-, MF59-, and ISCOM-Formulated Human Immunodeficiency Virus Type 1 Vaccines in Rhesus Macaques: Evidence for Viral Clearance
1999
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
DNA Vaccines: Progress and Challenges
2005
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
2002 StandoutNobel
DNA Immunization against Herpes Simplex Virus: Enhanced Efficacy Using a Sindbis Virus-Based Vector
1998
Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture
2003 StandoutNobel
DNA Vaccines: Immunology, Application, and Optimization
2000
Design and Characterization of Stabilized Derivatives of Human CD4D12 and CD4D1
2011 StandoutNobel
Reduction of Retrovirus-Induced Immunosuppression by In Vivo Modulation of T Cells during Acute Infection
2004 StandoutNobel
Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies
2002 StandoutNobel
Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+and CD4+T-Cell Responses from Chronically Infected Individuals
2001 StandoutNobel
The Host Defense of Drosophila melanogaster
2007 StandoutNobel
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20
2018 StandoutNobel
DNA vaccination: antigen presentation and the induction of immunity
2000
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
2006 StandoutScience
The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses
2004
Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine
1998 Science
Enhancement of Antibodies to the Human Immunodeficiency Virus Type 1 Envelope by Using the Molecular Adjuvant C3d
2003
Interactions between proteolytic and non-proteolytic Pseudomonas fluorescens affect protein degradation in a model community
2000
DNA VACCINES
1997
Noncytopathic Sindbis virus RNA vectors for heterologous gene expression
1998 StandoutNobel
Potent, protective anti-HIV immune responses generated by bimodal HIV envelope DNA plus protein vaccination
1997
Dendritic Cells, Infected with Vesicular Stomatitis Virus-Pseudotyped HIV-1, Present Viral Antigens to CD4+ and CD8+ T Cells from HIV-1-Infected Individuals
2000 StandoutNobel
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Prospects for the Future
2002 StandoutScienceNobel
Dengue and Dengue Hemorrhagic Fever
1998 Standout
Potent CD4+ T Cell Responses Elicited by a Bicistronic HIV-1 DNA Vaccine Expressing gp120 and GM-CSF
2002
Characterization of Hepatitis C Virus Core-Specific Immune Responses Primed in Rhesus Macaques by a Nonclassical ISCOM Vaccine
2001 StandoutNobel
Works of Daniel E. McCallus being referenced
Construction of a Recombinant Bacterial Human CD4 Expression System Producing a Bioactive CD4 Molecule
1992
Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo
1994
Cytokine Molecular Adjuvants Modulate Immune Responses Induced by DNA Vaccine Constructs for HIV-1 and SIV
1999
Identification of gene loci controlling pectate lyase production and soft-rot pathogenicity in Pseudomonas marginalis
1997
Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination
1997
Induction of Humoral and Cellular Immune Responses to the Human Immunodeficiency Type 1 Virus in Nonhuman Primates by in Vivo DNA Inoculation
1995
RNA interference-mediated prevention and therapy for hepatocellular carcinoma
2006
RNAi: gene-silencing in therapeutic intervention
2002
Biochemical and Genetic Characterization of an Extracellular Protease from Pseudomonas fluorescens CY091
1998
Isolated VH4 Heavy Chain Variable Regions Bind DNA Characterization of a Recombinant Antibody Heavy Chain Library Derived from Patient(s) with Active SLE
1994
Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time
1987